Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Using a credit line to pay off debt can be a strategic move. Discover smart tips that can help you manage your finances effectively.
26,415 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Broadcom's 2026 earnings outlook hinges on data center demand and enterprise IT budgets. This guide breaks down what ...
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Dave & Buster's is blending food, drinks, and arcade play into a growing business model. This analysis breaks down th...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
AI momentum has shifted, and Cerebras stock's volatility comes into sharper focus for investors. This guide breaks do...
A realized gain of $40,000 in 2025 could push 2027 Medicare costs higher for some retirees due to the two-year lookba...
The FCC is weighing a Know Your Customer style rule that would tie identity to every phone line. Privacy advocates wa...
Loan brokerages are expanding headcount and GCI, but margins are thinning. A new industry look shows why growth often...
Privacy-preserving crypto tools are meeting a hard policy edge. This article unpacks why developers feel at risk, wha...
Could SpaceX become a defining winner in a new era of commercial space? This guide breaks down how buying SpaceX toda...
Starbucks still faces investor headwinds as revenue grows slowly and profitability remains pressured. A closer look a...